Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8136)
All Articles published online
|
Publishing Process of This Article
|
Jul 7, 2023 (publication date) through Mar 15, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Pal SC, Méndez-Sánchez N. Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis. World J Gastroenterol 2023; 29(25): 3999-4008 [PMID: 37476582 DOI: 10.3748/wjg.v29.i25.3999] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Pal SC, Méndez-Sánchez N. Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis. World J Gastroenterol 2023; 29(25): 3999-4008 [PMID: 37476582 DOI: 10.3748/wjg.v29.i25.3999] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i25/3999.htm |
| Number | Citing Articles |
| 1 |
Jesica Martín-Carmona, Diana Corona-Mata, Francisco Téllez, Miguel Nicolás Navarrete Lorite, Isabel Barroso, Juan Carlos Alados, Rosario Palacios Muñoz, Ignacio de Los Santos, Francisco Jesús Vera-Méndez, Arkaitz Imaz, Miguel Raffo Márquez, Aitana Carla Morano Vázquez, María José Galindo, Olga Belinchón, Miriam Serrano Fuentes, Miguel Ángel López Zúñiga, Carlos Galera Peñaranda, Sergio Javier Reus-Bañuls, Juan A. Pineda, Juan Macías, Anaïs Corma-Gómez. Long-term liver stiffness dynamics after sustained virological response in patients with HIV/HCV co-infection and advanced fibrosis. AIDS 2026; 40(2): 151 doi: 10.1097/QAD.0000000000004357
|
| 2 |
Muhammad Shahzeb Khan, Syed Sarmad Javaid, Amreen Dinani, Kara Wegermann, Ambarish Pandey, Ankeet S. Bhatt, Mark Muthiah, Harriette G.C. Van Spall, Faiez Zannad, Javed Butler, Michael L. Volk, Marat Fudim. The Basics of Metabolic Dysfunction–Associated Steatotic Liver Disease for Cardiologists. JACC 2025; 86(20): 1861 doi: 10.1016/j.jacc.2025.08.100
|
| 3 |
Yigui Zou, Yu Dai, Ziyuan Li, Baixian Lin, Hu Chen, Zeling Zhuang, Wenwen Li, Qinghua Yang, Dongling Dai. Modified triglyceride-glucose indices as novel predictors of metabolic dysfunction-associated fatty liver disease in US adolescents: a nationally representative study from NHANES 2017–2020. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03915-x
|
| 4 |
Haixiang Zheng, Leonardo Antonio Sechi, Eliano Pio Navarese, Gavino Casu, Gianpaolo Vidili. Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review. Cardiovascular Diabetology 2024; 23(1) doi: 10.1186/s12933-024-02434-5
|
| 5 |
Claudia Reytor-González, Daniel Simancas-Racines, Martín Campuzano-Donoso, Janeth Castano Jimenez, Náthaly Mercedes Román-Galeano, Gerardo Sarno, Evelyn Frias-Toral. Harnessing nutrition to combat MASLD: a comprehensive guide to food-based therapeutic strategies. Food and Agricultural Immunology 2025; 36(1) doi: 10.1080/09540105.2025.2496499
|
| 6 |
Jingyuan Ma, Yanna Ma, Xing Wan, Junchen Li, Yunshu Zhang, Jifeng Liu, Yunhai Gao. Metabolic and genetic mechanisms of metabolic dysfunction-associated steatotic liver disease: an integrative perspective from molecular pathways to clinical challenges. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1639064
|
| 7 |
Supriyo Ghosh, Amlan Jyoti Ghosh, Rejuan Islam, Sagar Sarkar, Tilak Saha, Ahmed Khalafallah Sadeq Rashwan. Lactobacillus plantarum KAD protects against high-fat diet-induced hepatic complications in Swiss albino mice: Role of inflammation and gut integrity. PLOS ONE 2024; 19(11): e0313548 doi: 10.1371/journal.pone.0313548
|
| 8 |
Yingyong Ou, Zihan Qin, Pinze Wang, Fan Zou. Serum uric acid to high-density lipoprotein cholesterol ratio predicts all-cause mortality in adults with metabolic dysfunction associated steatotic liver disease. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-94651-5
|
| 9 |
Peter Chinedu Agu, Jun Lu. Hidden Hunger: A Forgotten Comorbidity of Metabolic‐Syndrome‐Associated Fatty Liver Disease. Molecular Nutrition & Food Research 2025; 69(19) doi: 10.1002/mnfr.70134
|
| 10 |
Vlad Alexandru Ionescu, Gina Gheorghe, Nicolae Bacalbasa, Camelia Cristina Diaconu. Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk. Biomolecules 2025; 15(2): 163 doi: 10.3390/biom15020163
|
| 11 |
Yiming Chen, Haryo Raden Himan, Yalkin Yazicioglu, Rachel Goh, Yip Han Chin, Bryan Chong, Srinithy Nagarajan, Martin Tze Wah Kueh, Jiong-Wei Wang, Mark M Muthiah, Xin Zhou, Mark Y Chan, Anurag Mehta, Mamas A Mamas, Muhammad Shahzeb Khan, Nicholas WS Chew. Population estimates, trends, characteristics and prognostic outcomes of cardiovascular-kidney-liver-metabolic health: A population-based study. American Journal of Preventive Cardiology 2026; 25: 101405 doi: 10.1016/j.ajpc.2025.101405
|
| 12 |
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, Adriano Cressoni Araújo, Ricardo de Alvares Goulart, Marcelo Dib Bechara, Lucas Fornari Laurindo, Nahum Méndez-Sánchez, Sandra Maria Barbalho. Underlying Mechanisms behind the Brain–Gut–Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update. International Journal of Molecular Sciences 2024; 25(7): 3694 doi: 10.3390/ijms25073694
|
| 13 |
Nikos Adamidis, Petros Papalexis, Sotirios Adamidis. Exploring the Link Between Metabolic Syndrome and Cellulite. Cureus 2024; doi: 10.7759/cureus.63464
|
| 14 |
Nouhoum Bouare, Jean Delwaide. Interleukin-mediated therapies in liver diseases and comorbidity effects. World Journal of Hepatology 2024; 16(7): 980-989 doi: 10.4254/wjh.v16.i7.980
|
| 15 |
Yiwei Yuan, Mingxiu Gong, Ruili Pan, Xiaolei Shi, Xiaojun Li, Hao Huang, Jin Zhao. Artificially fermented dark loose tea ameliorates metabolic-associated fatty liver disease by activating the PI3K/AKT signalling pathway and regulating gut microbiota dysbiosis. Food Chemistry: X 2025; 31: 103099 doi: 10.1016/j.fochx.2025.103099
|
| 16 |
Yu Min, Xiaoyuan Wei, Zhigong Wei, Ge Song, Xin Zhao, Yi Lei. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease. Cardiovascular Diabetology 2024; 23(1) doi: 10.1186/s12933-024-02287-y
|
| 17 |
Pegah Rashidian, Mohit Mirchandani, Kavya Priya Somu, Saisree Reddy Adla Jala, Abinash Mahapatro, Seyyed Mohammad Hashemi, Amir Nasrollahizadeh, Farahnaz Joukar, Reza Eshraghi, Negin Letafatkar, Ehsan Amini-Salehi. Association between atherogenic index of plasma and various metabolic conditions: an umbrella review on meta-analyses. BMC Cardiovascular Disorders 2025; 26(1) doi: 10.1186/s12872-025-05409-w
|
| 18 |
Milena Vesković, Nikola Šutulović, Dragan Hrnčić, Olivera Stanojlović, Djuro Macut, Dušan Mladenović. The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease—The Transition from an Adipocentric to Liver-Centric Approach. Current Issues in Molecular Biology 2023; 45(11): 9084 doi: 10.3390/cimb45110570
|
| 19 |
Yijun Wu, Jingfang Xiong, Gaofeng Chen, Yihui Liu, Changqing Zhao, Zhaolin Zhang, Hong Xu. Oxymatrine relieves non-alcoholic fatty liver disease by promoting sirtuin 1/adenosine 5‘-monophosphate-activated protein kinase pathway and peroxisome proliferator activated receptor alpha-mediated hepatic fatty acid oxidation. European Journal of Pharmacology 2025; 987: 177173 doi: 10.1016/j.ejphar.2024.177173
|
| 20 |
Anoushka Shenoy, Aijaz Ahmed, Donghee Kim. Extrahepatic manifestation of metabolic dysfunction-associated steatotic liver disease. Metabolism and Target Organ Damage 2025; 5(3) doi: 10.20517/mtod.2025.73
|
| 21 |
Qiuping Wang, Yuan Su, Jing Niu, Yan Wang, Liping Liu, Yanhong Hao, Qian Wu. Nonlinear association between TyG-BMI and MAFLD: A cross-sectional study. PLOS One 2025; 20(10): e0331140 doi: 10.1371/journal.pone.0331140
|
| 22 |
Hiroki Nishikawa, Soo Ki Kim, Akira Asai. Body Composition in Chronic Liver Disease. International Journal of Molecular Sciences 2024; 25(2): 964 doi: 10.3390/ijms25020964
|
| 23 |
Miranda Sol Orellano, Andrea Scelza-Figueredo, Lucía Lameroli Mauriz, Carolina Sétula, Milagros Argañarás, Catalina Atorrasagasti, Marcelo Javier Perone, Luz Andreone. A dissociated glucocorticoid receptor modulator mitigates glucolipotoxicity in the endocrine pancreas and peripheral tissues: Preclinical data from a mouse model of diet-induced type 2 diabetes. Life Sciences 2025; 362: 123363 doi: 10.1016/j.lfs.2024.123363
|
| 24 |
Dake Wen, Ru Yan, Jian He, Ling Gu, Xu-Yang Chen, Kai Wang. Investigating the efficacy of a photoacoustic probe in liver function assessment for diabetic mellitus. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2025; 342: 126490 doi: 10.1016/j.saa.2025.126490
|
| 25 |
Yi Li, Shuyu Kang, Qiwen Wang, Congyan Zeng, Gengting Dong. Bidens biternata (Lour.) Merr. & Sherff improves liver lipid metabolism disorders in type 2 diabetic mice by activating mitophagy. Journal of Ethnopharmacology 2026; 357: 120877 doi: 10.1016/j.jep.2025.120877
|
| 26 |
Anton Bermont, Daniel L. Cohen, Vered Richter, Rivka Hadar, Joseph Tam, Ayelet Wandel, Solli Brawer, Omer Grundman, Haim Shirin. FucoVital® inhibits fatty acid accumulation in liver cells in vitro and reduces triglycerides levels in patients with NAFLD. PharmaNutrition 2025; 31: 100429 doi: 10.1016/j.phanu.2025.100429
|
| 27 |
Abdul Hamid Zargar, Anil Bhansali, Anirban Majumdar, Anuj Maheshwari, Arpandev Bhattacharyya, Arundhati Dasgupta, Banshi Damodarlal Saboo, Bipin Kumar Sethi, Debmalya Sanyal, Krishna G. Seshadri, Neeta Rohit Deshpande, Nitin Kapoor, Om Jitendra Lakhani, Pradeep Gopal Talwalkar, Pramila Kalra, Rabindera Nath Mehrotra, Rakesh Kumar Sahay, Rishi Shukla, Saket Kant, Sambit Das, Sanjay Chunilal Agarwal, Sanjeev Ratnakar Phatak, Shanmugasundar G., Shashank Rameshchandra Joshi, Shehla Sajid Shaikh, Sosale Ramachandra Aravind, Soumik Goswami, Sujoy Ghosh, Vijay Kumar Panikar, Viswanathan Mohan. Management of metabolic dysfunction–associated steatotic liver disease (MASLD)—An expert consensus statement from Indian diabetologists' perspective. Diabetes, Obesity and Metabolism 2025; 27(S4): 3 doi: 10.1111/dom.16496
|
| 28 |
Jorge Arnold, Francisco Idalsoaga, Luis Antonio Díaz, Daniel Cabrera, Francisco Barrera, Juan Pablo Arab, Marco Arrese. Emerging Drug Therapies for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Glimpse into the Horizon. Current Hepatology Reports 2024; 23(1): 204 doi: 10.1007/s11901-023-00629-0
|
| 29 |
Li-Na Qin, Yun-Feng Yu, Lie Ma, Rong Yu. Intestinal bacteria-derived extracellular vesicles in metabolic dysfunction-associated steatotic liver disease: From mechanisms to therapeutics. Molecules and Cells 2025; 48(6): 100216 doi: 10.1016/j.mocell.2025.100216
|
| 30 |
Giovanna Gallo, Gabriele Nalli, Francesco Baratta, Giovambattista Desideri, Carmine Savoia. Metabolic Dysfunction-Associated Steatotic Liver Disease: A Silent Driver of Cardiovascular Risk and a New Target for Intervention. International Journal of Molecular Sciences 2025; 26(16): 8081 doi: 10.3390/ijms26168081
|
| 31 |
Ehsan Bahrami Hezaveh, Rana Hashemi, Mohammadamin Noorafrooz, Mohsen Sheikhzadeh, Azin Ebrahimi, Amirhossein Yadegar, Manouchehr Nakhjavani, Alireza Esteghamati, Soghra Rabizadeh. Comparing the diagnostic performance of metabolic indices in metabolic dysfunction-associated fatty liver disease patients: a retrospective cross-sectional study. European Journal of Medical Research 2026; 31(1) doi: 10.1186/s40001-026-03935-7
|
| 32 |
Sakeena Noor, Fakhria A Al-Joufi, Ambreen Malik Uttra, Sumera Qasim, Aiman Afzal. Protective role of geraniol in high fat diet-induced NAFLD: balancing lipid homeostasis, antioxidant defence, and inflammatory responses. Journal of Pharmacy and Pharmacology 2025; 77(10): 1439 doi: 10.1093/jpp/rgaf053
|
| 33 |
Songyuan Tang, Guangli Yan, Ling Kong, Hui Sun, Chang Liu, Ying Han, Xijun Wang. Research progress on the hepatoprotective effect, pharmacokinetic properties, and hepatotoxicity of geniposide. Acupuncture and Herbal Medicine 2025; 5(2): 136 doi: 10.1097/HM9.0000000000000160
|
| 34 |
Alfredo Caturano, Enes Erul, Roberto Nilo, Davide Nilo, Vincenzo Russo, Luca Rinaldi, Carlo Acierno, Erman Akkus, Katerina Koudelkova, Federica Cerini, Alessandro Rizzo, Ferdinando Carlo Sasso, Leonilde Bonfrate, Antonio Giordano, Hatime Arzu Yaşar, Caterina Conte. Metabolic dysfunction‐associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triad. European Journal of Clinical Investigation 2026; 56(1) doi: 10.1111/eci.70132
|
| 35 |
Attia Mustafa, Chris Kite, Lukasz Lagojda, Alexander Dallaway, Kamaljit Kaur Chatha, Nwe Ni Than, Eva Kassi, Ioannis Kyrou, Harpal S. Randeva. Cardiovascular Disease in the Context of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Comprehensive Narrative Review. International Journal of Molecular Sciences 2025; 26(23): 11275 doi: 10.3390/ijms262311275
|
| 36 |
Lijuan Liu, Weiming Sun, Xulei Tang, Donghu Zhen, Conghui Guan, Songbo Fu, Jinjin Liu. Chiglitazar attenuates high-fat diet-induced nonalcoholic fatty liver disease by modulating multiple pathways in mice. Molecular and Cellular Endocrinology 2024; 593: 112337 doi: 10.1016/j.mce.2024.112337
|
| 37 |
Qian Xue, Hongju Chen. Association of blood manganese levels with non-alcoholic fatty liver disease in NHANES 2017–2020: A retrospective cross-sectional study. Metabolism Open 2025; 26: 100358 doi: 10.1016/j.metop.2025.100358
|
| 38 |
Jiquan Xiao, Song Wen, Yusi Huang, Xiang He, Yihan Weng, Huimin Yu. The Role of Insulin Resistance in Cardiorenal Metabolic Syndrome. Cardiology in Review 2025; doi: 10.1097/CRD.0000000000001048
|
| 39 |
Pongsakorn Taweesap, Prapassorn Potue, Juthamas Khamseekaew, Metee Iampanichakul, Banyaphon Jan-O, Poungrat Pakdeechote, Putcharawipa Maneesai. Luteolin Relieves Metabolic Dysfunction-Associated Fatty Liver Disease Caused by a High-Fat Diet in Rats Through Modulating the AdipoR1/AMPK/PPARγ Signaling Pathway. International Journal of Molecular Sciences 2025; 26(8): 3804 doi: 10.3390/ijms26083804
|
| 40 |
Raissa Bulaty Tauil, Paula Takano Golono, Enzo Pereira de Lima, Ricardo de Alvares Goulart, Elen Landgraf Guiguer, Marcelo Dib Bechara, Claudia C. T. Nicolau, José Luiz Yanaguizawa Junior, Adriana M. R. Fiorini, Nahum Méndez-Sánchez, Ludovico Abenavoli, Rosa Direito, Vitor Engrácia Valente, Lucas Fornari Laurindo, Sandra Maria Barbalho. Metabolic-Associated Fatty Liver Disease: The Influence of Oxidative Stress, Inflammation, Mitochondrial Dysfunctions, and the Role of Polyphenols. Pharmaceuticals 2024; 17(10): 1354 doi: 10.3390/ph17101354
|
| 41 |
Júlia Mayumi Tomaru, Iara Ribeiro Nunes, Caroline Fernandes de Souza Santiago, Alda Maria Machado Bueno Otoboni, Claudemir Gregorio Mendes, Adriana Maria Ragassi Fiorini, Elen Landgraf Guiguer, Claudia Cristina Teixeira Nicolau, Antonelly Cassio Alves Carvalho, Caio Sérgio Galina Spilla, José Luiz Yanaguizawa Junior, Vitor Engrácia Valenti, Ricardo de Alvares Goulart, Luiz Carlos de Abreu, Lucas Fornari Laurindo, Sandra Maria Barbalho. Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors. Nutrients 2026; 18(4): 636 doi: 10.3390/nu18040636
|
| 42 |
Milkiyas T. Tantu, Fatema Z. Farhana, Farjana Haque, Kevin M. Koo, Liang Qiao, Allen G. Ross, Muhammad J. A. Shiddiky. Pathophysiology, noninvasive diagnostics and emerging personalized treatments for metabolic associated liver diseases. npj Gut and Liver 2025; 2(1) doi: 10.1038/s44355-025-00030-2
|
| 43 |
Shuting Xu, Guangyi Liao, Tingting Li, Wenmin Li, Wanli Huang, Lihaopeng Cao, Shanshan Chen, Xiao Yang, Tianle Qin, Yuqing Zhou, Rong Yu, Chuanquan Lin. Taraxasterol from dandelion improves glycolipid metabolism dysfunction in diet-induced metabolic dysfunction-associated steatotic liver disease by modulating hepatic FXR. Journal of Ethnopharmacology 2026; 359: 121068 doi: 10.1016/j.jep.2025.121068
|
| 44 |
Yulei Lu, Fei Yi, Wende Chen, Xinglong Tan, Kezhi Li, Chun Yang, Youzhi Lin. Involvement of oxidative stress, lipid dysmetabolism and gut microbiol dysbiosis in oxaliplatin-induced fatty liver disease: evidence from a tree shrew model. Clinics and Research in Hepatology and Gastroenterology 2025; 49(7): 102645 doi: 10.1016/j.clinre.2025.102645
|
| 45 |
Mohammadjavad Sotoudeheian. Agile 3+ and Metabolic Dysfunction-Associated Fatty Liver Disease:
Detecting Advanced Fibrosis based on Reported Liver Stiffness
Measurement in FibroScan and Laboratory Findings. The International Journal of Gastroenterology and Hepatology Diseases 2024; 3 doi: 10.2174/0126662906302851240604042954
|
| 46 |
Richard H. Goodheart, Oyekoya T. Ayonrinde. Connecting the Dots: Hepatic Steatosis as a Central Player in the Choreography of the Liver-Cardiovascular-Kidney-Metabolic Syndrome. Heart, Lung and Circulation 2025; 34(10): 1050 doi: 10.1016/j.hlc.2025.08.009
|
| 47 |
Xiuxian Huang, Zhengming Li, Zhenwei Zhai, Qiu Wang, Rongyan Wei, Jiacheng Mo, Jianhao Huang, Wensheng Lu. Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and MACCEs in Patients with Diabetic Foot Ulcers: An Ambispective Longitudinal Cohort Study. Diabetes, Metabolic Syndrome and Obesity 2024; : 1119 doi: 10.2147/DMSO.S447897
|
| 48 |
Hassam Ali, Muhammad Shahzil, Vishali Moond, Maria Shahzad, Abhay Thandavaram, Alina Sehar, Haniya Waseem, Taha Siddiqui, Dushyant Singh Dahiya, Pratik Patel, Hans Tillmann. Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice. Journal of Personalized Medicine 2024; 14(1): 61 doi: 10.3390/jpm14010061
|
| 49 |
Arthur Cicupira Rodrigues de Assis, Paulo Cury Rezende, Whady Hueb, Ary Serpa Neto, Thiago Luis Scudeler, Rosa Maria Rahmi Garcia, Vitor Coutinho Andrade, Marcela Francisca da Silva, Matheus de Oliveira Laterza Ribeiro, Mauricio Rigodanzo Mocha, Maria Stanislavovna Tairova, Luciano da Silva Selistre, Paulo Rogerio Soares, Jose Antonio Franchini Ramires, Roberto Kalil Filho. Association of longitudinal triglyceride levels with cardiovascular events in multivessel coronary artery disease. European Journal of Preventive Cardiology 2025; doi: 10.1093/eurjpc/zwaf192
|
| 50 |
Nahum Méndez-Sánchez, Mariana M. Ramírez-Mejía, Mohammed Eslam. Metabolic Dysfunction-Associated Steatotic Liver Disease. 2024; : 1 doi: 10.1007/978-981-97-9519-2_1
|
| 51 |
Ashay Shah, Arifa Bakerywala, Riya N. Brahmbhatt, Heena Shaikh, Nidhi Shashikant Bhutak, Renu Singh. The Occurrence of Non-Alcoholic Fatty Liver Disease among Individuals with Diabetes Mellitus: A Comparative Study. Journal of Pharmacy and Bioallied Sciences 2025; 17(Suppl 1): S767 doi: 10.4103/jpbs.jpbs_2016_24
|
| 52 |
Anxin Wang, Xue Tian, Qiqi Deng, Manqi Zheng, Xue Xia, Yijun Zhang, Yan Tan, Qian Hua. Longitudinal association of metabolic dysfunction-associated fatty liver disease, serum metabolites, with cognitive function trajectories. npj Metabolic Health and Disease 2025; 3(1) doi: 10.1038/s44324-025-00055-4
|
| 53 |
Marko Mrdjen, Jared Travers, Laura E. Nagy. Comprehensive Toxicology. 2026; : 312 doi: 10.1016/B978-0-323-95488-4.00079-6
|
| 54 |
Huiting Xi, Zhongwei Liu, Weixiang Xu, Jiexue Zhao, Yuanxing Wang, Jianhua Xie. Triterpenoids from
Cyclocarya paliurus: structure, biosynthesis, biological activities
. Food Science and Human Wellness 2025; 14(6): 9250127 doi: 10.26599/FSHW.2024.9250127
|
| 55 |
Shreya C. Pal, Stephany M. Castillo-Castañeda, Luis E. Díaz-Orozco, Mariana M. Ramírez-Mejía, Rita Dorantes-Heredia, Rogelio Alonso-Morales, Mohammed Eslam, Frank Lammert, Nahum Méndez-Sánchez. Molecular Mechanisms Involved in MAFLD in Cholecystectomized Patients: A Cohort Study. Genes 2023; 14(10): 1935 doi: 10.3390/genes14101935
|
| 56 |
Mohammadjavad Sotoudeheian. Value of Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) in Assessing Liver Fibrosis in Metabolic Dysfunction-Associated Liver Disease: A Comprehensive Review of its Serum Biomarker Role. Current Protein & Peptide Science 2025; 26(1): 6 doi: 10.2174/0113892037315931240618085529
|
| 57 |
Nahum Méndez-Sánchez, Mariana M. Ramírez-Mejía, Xingshun Qi. Metabolic Dysfunction-Associated Steatotic Liver Disease. 2024; : 7 doi: 10.1007/978-981-97-9519-2_2
|
| 58 |
Deok Jae Lee, Sun Young Park, Se Hoon Kim, Jae Ho Yeom, Na-Hyun Lee, Yong Hoon Joo, Namhyun Chung. Flavonoids and their role in obesity management. Journal of Applied Biological Chemistry 2025; 68 doi: 10.3839/jabc.2025.050
|
| 59 |
Othman A. Alghamdi. Pancreatic Lipase Inhibitors as Therapeutic Agents for Metabolic Disorders: Advances in Molecular Biology and Biotechnology: A Review. Industrial Biotechnology 2026; 22(1): 51 doi: 10.1177/15509087251389397
|
| 60 |
Houssem Chenna, Yahia Khelef, Imen Halimi, Kahina Boudjema, Chaouki Djouder, Ilham Allala, Mahieddine Boumendjel, Amel Boumendjel, Mahfoud Messarah.
Protective effects of
Matricaria pubescens
powder against high-fat diet-induced oxidative stress in rat adipose tissue
. Egyptian Journal of Basic and Applied Sciences 2025; 12(1): 501 doi: 10.1080/2314808X.2026.2612678
|
| 61 |
Tomasz Szkudelski, Katarzyna Szkudelska. The Anti-Diabetic Potential of Baicalin: Evidence from Rodent Studies. International Journal of Molecular Sciences 2023; 25(1): 431 doi: 10.3390/ijms25010431
|
| 62 |
Qianzhuo Wang, Yingjuan Zhang, Ruiling Lu, Qingwen Zhao, Yue Gao. The multiple mechanisms and therapeutic significance of rutin in metabolic dysfunction-associated fatty liver disease (MAFLD). Fitoterapia 2024; 178: 106178 doi: 10.1016/j.fitote.2024.106178
|